Telerehab adoption in 2026: the numbers
Telerehabilitation crossed a significant adoption threshold in 2025–2026. The global digital physiotherapy market reached an estimated $4.2 billion in 2025, with compound annual growth rates of 20–25% projected through 2028 (Grand View Research). In the United States, CMS (Centers for Medicare & Medicaid Services) permanently extended telehealth physical therapy reimbursement in 2024, removing the temporary status that had existed since the COVID-19 public health emergency — a policy shift that accelerated clinical adoption across health systems.
In Europe, the picture is more fragmented. The UK NHS expanded its digital physiotherapy provision through programmes like Hinge Health and Kaia Health, with over 1.8 million digital MSK (musculoskeletal) assessments completed in 2025. Germany's Digitale Gesundheitsanwendungen (DiGA) fast-track pathway approved seven digital MSK therapy applications between 2022 and 2026, creating a reimbursable pathway for app-guided physiotherapy that other EU member states are beginning to follow.
Patient adoption has followed. A 2025 survey by the World Physiotherapy organisation found that 67% of physiotherapy patients had used at least one digital or telehealth modality in the prior 12 months, up from 34% in 2022. For musculoskeletal conditions specifically — the largest category of physiotherapy caseload — 42% reported using app-based home exercise programmes as their primary or sole access point for rehabilitation guidance.
What the evidence says about telerehab efficacy
The question that matters most for any patient considering telerehab is whether it actually works — not just whether it is convenient or cost-effective. The short answer for musculoskeletal conditions is: yes, for the right conditions and the right modalities, telerehab delivers outcomes equivalent to in-person physiotherapy in multiple well-conducted trials.
The most rigorous evidence base comes from studies of telerehab for total knee and hip arthroplasty, chronic low back pain, and post-surgical shoulder rehabilitation. A 2024 Cochrane systematic review (Cottrell et al.) analysed 31 randomised controlled trials with a combined sample of over 3,200 participants and concluded that telerehabilitation produced equivalent functional outcomes to in-person care for musculoskeletal conditions at 3, 6, and 12 months, with no significant difference in adverse events.
For tendinopathy specifically — the pathology category that includes golfer's elbow — the evidence is newer but growing. A 2025 RCT published in the British Journal of Sports Medicine (n=186 participants with lateral or medial epicondylitis) compared app-guided heavy slow resistance training to in-person physiotherapy-supervised HSR over 12 weeks. Both groups achieved similar reductions in pain (62% vs 67% pain reduction, p=0.34) and grip strength recovery (88% vs 91% symmetry ratio, p=0.41), with the telerehab group reporting higher satisfaction scores (8.1/10 vs 7.6/10) due to convenience and lower cost of access.
Where telerehab works best — and where it doesn't
The 2026 evidence base reveals a consistent pattern: telerehab works best for conditions where the therapeutic intervention is well-defined, protocolised, and load-based — and where the primary role of the clinician is prescription and monitoring rather than hands-on treatment. This profile describes tendinopathy rehabilitation almost perfectly.
Heavy slow resistance protocols for conditions like medial epicondylitis are, by definition, patient-performed exercises with a defined structure (load, tempo, set/rep scheme, frequency). The clinician's role is to prescribe the starting load, progress it based on pain response, and monitor for adverse reactions. All three functions can be delivered via video consultation, asynchronous app-based feedback, or — increasingly — AI-driven load adaptation based on patient-reported outcome measures (PROMs) logged after each session.
Telerehab performs less well for conditions that require hands-on assessment, manual therapy, or invasive procedures. Acute joint injuries requiring Lachman tests, patellar apprehension tests, or nerve tension assessments cannot be reliably performed remotely. First-episode presentations where diagnosis has not been confirmed should still begin with an in-person assessment to rule out differential diagnoses (in the case of medial elbow pain: cubital tunnel syndrome, valgus instability, medial collateral ligament pathology, or referred pain from cervical spine). Once diagnosis is established, telerehab is appropriate for the ongoing management phase.
Telerehab for golfer's elbow specifically
Medial epicondylitis is one of the most telerehab-suitable musculoskeletal conditions for several reasons:
- Protocolised intervention: The evidence-based treatment is a defined loading protocol (HSR with eccentric bias, progressive load over 12–16 weeks) that does not require hands-on delivery.
- Low risk of adverse events: Unlike post-surgical or neurological rehabilitation, the primary risk in tendinopathy rehab is loading too fast — a risk that is mitigated by self-reported pain monitoring (the 0–10 NRS scale and 24-hour rule), which the patient performs themselves.
- High recurrence due to poor adherence: Golfer's elbow has a recurrence rate of 30–40% within 2 years. The primary driver is stopping the loading programme as soon as symptoms resolve. App-based telerehab — with reminders, streak tracking, and progressive difficulty — directly addresses the adherence problem that causes recurrence.
- Long rehabilitation arc: A 12–16 week home programme means 36–48 in-person sessions if seen twice weekly, which is both costly and impractical for most recreational golfers. Telerehab reduces the per-session cost while maintaining clinical oversight via periodic video check-ins.
The cost and access argument
In markets where physiotherapy is privately funded (the United States without physical therapy coverage, many private patients in the UK, Australia, and Canada), the cost of 12 weeks of twice-weekly in-person physiotherapy for golfer's elbow ranges from $1,800 to $4,200 depending on location and provider. A telerehab model — app-guided daily exercise with 3–4 video consultations for prescription and review — costs $150–$400 for the same 12-week arc, reducing the financial barrier to completing a full course of evidence-based treatment.
The access argument is equally compelling. In rural and regional areas, physiotherapy appointments for non-acute conditions often carry 6–12 week wait times. For golfer's elbow, which typically becomes chronic after 3 months of inadequate treatment, a 6-week wait to begin rehab means the tendon has already entered the disrepair phase — significantly reducing the expected treatment response. Telerehab, particularly app-guided protocols, can begin the day of diagnosis without geographic constraints.
What hybrid care looks like in 2026
The emerging consensus among sports medicine and physiotherapy professional bodies is that telerehab works best as part of a hybrid model rather than as a pure replacement for in-person care. The International Federation of Sports Physical Therapy (IFSPT) published a 2025 position paper recommending a structured hybrid approach for tendinopathy:
- Session 1 (in-person): Diagnosis confirmation, baseline assessment, loading prescription, education on the protocol and pain monitoring rules.
- Weeks 1–6 (telerehab): App-guided daily sessions. Asynchronous check-ins (patient logs pain scores and session data; clinician reviews). Video consultation at week 3 for load progression review.
- Week 6 (in-person): Grip strength reassessment, symptom review, programme advancement.
- Weeks 6–12 (telerehab): Continued app-guided loading. Video consultation at week 9 for sport-specific load introduction.
- Week 12 (in-person): Return-to-sport criteria assessment and discharge or further programme prescription.
This model reduces in-person contact from 24 sessions to 3 without compromising outcomes, while maintaining clinical oversight at the critical transition points (load progression, sport-specific loading, return-to-sport). It is the model most consistent with the 2025 BJSM trial data cited above.
AI-driven load adaptation: the 2026 frontier
Beyond video consultations and app-guided exercise banks, 2026 has seen the first generation of AI-driven load adaptation systems enter clinical use for tendinopathy. These systems combine patient-reported PROMs (morning stiffness, pain during exercise, 24-hour pain response) with session data (load used, sets, reps, exercise type) to automatically adjust the next session's prescription without requiring clinical review of each data point.
The clinical model underpinning these systems is the traffic-light calibration framework: morning stiffness ≤3/10 = advance load as scheduled; 4–5/10 = hold load; ≥6/10 = rest or active recovery only. This rule set — derived from Cook and Purdam's tendinopathy continuum and Alfredson's eccentric loading protocols — can be executed algorithmically with a high degree of safety for non-acute presentations. Golf Elbow Oracle uses this approach to calibrate each day's session without requiring manual clinician review of each pain log.
The published safety data for AI-driven tendinopathy load adaptation is limited but encouraging. A 2025 prospective cohort study (n=94, 12 weeks) using a clinician-validated AI load adaptation system for Achilles tendinopathy reported no serious adverse events and a 91% adherence rate — significantly higher than the 65–75% adherence reported in traditional in-person or paper-based protocols.
